[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100053935":3},{"organization":4,"outcomesModule":7,"designInfo":27,"detailedDescription":26,"studyPopulation":26,"armGroups":33,"interventions":40,"overallOfficials":26,"centralContacts":46,"locations":52,"responsibleParty":77,"collaborators":26,"id":79,"slug":26,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":26,"eligibilityCriteria":84,"healthyVolunteers":80,"sex":85,"minAge":86,"maxAge":26,"enrollmentInfo":87,"targetDuration":26,"studyType":90,"phases":91,"briefSummary":93,"conditions":94,"keywords":99,"overallStatus":55,"whyStopped":26,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"Mahidol University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":26},[9],{"measure":10,"description":11,"timeFrame":12},"complete response rate","no vomiting and no rescue therapy","5 days after receiving chemotherapy",[14,17,20,22],{"measure":15,"description":16,"timeFrame":12},"no -nausea rate","no nausea symptom",{"measure":18,"description":19,"timeFrame":12},"degree of nausea vomiting","grading of nausea vomiting",{"measure":21,"description":21,"timeFrame":12},"adverse effects",{"measure":23,"description":24,"timeFrame":25},"rescue therapy","additional treatment for nausea or vomiting","5 days after chemotherapy",null,{"allocation":28,"interventionModel":29,"interventionModelDescription":26,"primaryPurpose":30,"observationalModel":26,"timePerspective":26,"maskingInfo":31},"NA","SINGLE_GROUP","PREVENTION",{"masking":32,"maskingDescription":26,"whoMasked":26},"NONE",[34],{"label":35,"type":36,"description":37,"interventionNames":38},"study arm","EXPERIMENTAL","olanzapine palonosetron with dexamethasone on day 1 only",[39],"Drug: dexamethasone sparing",[41],{"type":42,"name":43,"description":44,"armGroupLabels":45,"otherNames":26},"DRUG","dexamethasone sparing","omit dexamethasone on day 2-4",[35],[47],{"name":48,"role":49,"phone":50,"phoneExt":26,"email":51},"Suthinee Ithimakin","CONTACT","+66898127440","aesi105@yahoo.co.th",[53],{"facility":54,"status":55,"city":56,"state":26,"zip":57,"country":58,"countryCode":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"Faculty of Medicine Siriraj Hospital, Mahidol University","RECRUITING","Bangkok","10700","Thailand","TH",{"type":61,"coordinates":62},"Point",[63,64],100.50144,13.75398,{"lat":64,"lon":63},[67,69,72,75],{"name":48,"role":49,"phone":68,"phoneExt":26,"email":51},"0898127440",{"name":70,"role":71,"phone":26,"phoneExt":26,"email":26},"Sirisopa Techawattanawanna, M.D","PRINCIPAL_INVESTIGATOR",{"name":73,"role":74,"phone":26,"phoneExt":26,"email":26},"Akarin Nimmannit, M.D","SUB_INVESTIGATOR",{"name":76,"role":74,"phone":26,"phoneExt":26,"email":26},"Visullaya Sa-nguanwongwan, M.D",{"type":78,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100053935",false,"NCT07699276","Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin","Steroid-sparing Regimen With Olanzapine and Ondansetron to Prevent Emesis Caused by High Dose Cisplatin in Solid Cancer Patient : A Single Arm Phase II Study","Inclusion Criteria:\n\n* histologically confirmed solid malignancy\n* scheduled for first cycle of cisplatin at dosage of at least 50 mg\u002Fm2\n\nExclusion Criteria:\n\n* pregnancy\n* pelvic or abdominal radiation within 4 weeks\n* uncontrolled brain metastasis\n* other moderate or high emetic risk chemotherapy on day 2-5\n* untreated gut obstruction\n* known allergy or severe adverse effect from palonosetron or olanzapine\n* AST\u002F ALT \\> 2.5x or serum creatinine clearance less than 50 ml\u002Fmin","ALL","18 Years",{"count":88,"type":89},95,"ESTIMATED","INTERVENTIONAL",[92],"PHASE2","A phase II study evaluating dexamethasone sparing regimen with olanzapine and palonosetron for patients receiving high dose cisplatin to prevent chemotherapy induced nausea and vomiting",[95,96,97,98],"Cancer (Solid Tumors)","Vomiting","Cisplatin","Olanzapine",[100,101,43,102],"cisplatin","chemotherapy induced nausea vomiting","olanzapine","2026-07-07",{"date":105,"type":106},"2026-07-13","ACTUAL",{"date":108,"type":106},"2026-02-10",{"date":110,"type":89},"2027-11-15",{"name":5,"class":6},1]